JAMA Oncology

Oncology & Cancer

New cancer immunotherapy drugs rapidly reach patients after approval

The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies ...

Oncology & Cancer

Breast cancer genes a real risk for men, too

(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

Oncology & Cancer

Blood cancer precursor found in 9/11 firefighters

A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...

Oncology & Cancer

Patients prefer doctors who engage in face-to-face visits

(HealthDay)—Patients prefer physicians who engage in face-to-face (F2F) clinic visits, rather than those using an examination room computer (ERC), according to a research letter published online April 19 in JAMA Oncology.

Oncology & Cancer

Males with BRCA mutations have increased risk of certain cancers

(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a research letter published online April 12 in JAMA Oncology.

Oncology & Cancer

Want to help beat colon cancer? Live healthy

(HealthDay)—More than 1.3 million Americans are diagnosed with colon cancer, but new research suggests that adopting a healthy lifestyle goes a long way toward boosting survival.

page 37 from 40